A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)
Incyte Corporation
Incyte Corporation
PharmaMar
Bayer
Cedars-Sinai Medical Center
BerGenBio ASA
Blueprint Medicines Corporation
University Hospital, Antwerp
Cedars-Sinai Medical Center
Celgene
Novo Nordisk A/S
Sumitomo Pharma America, Inc.
SCRI Development Innovations, LLC
Karyopharm Therapeutics Inc
Quadriga Biosciences, Inc.
Celgene
Gilead Sciences
Celldex Therapeutics
Stanford University
Icahn School of Medicine at Mount Sinai
Swiss Cancer Institute
Centre Georges Francois Leclerc
Stanford University
Ohio State University Comprehensive Cancer Center
M.D. Anderson Cancer Center
Genentech, Inc.
National Cancer Institute (NCI)
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Cedars-Sinai Medical Center
Dana-Farber Cancer Institute
Case Comprehensive Cancer Center
Pharmacyclics LLC.